Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer.

1. Juni 2011

Stemmler, H.J., Digioia, D., Freier, W., Tessen, H.W., Gitsch, G., Jonat, W., Brugger, W., Kettner, E., Abenhardt, W., Tesch, H., Hurtz, H.J., Rösel, S., Brudler, O., Heinemann, V., 2011.

Br J Cancer 104, 1071–1078. doi:10.1038/bjc.2011.86

Abstract